Clover Health Investments (CLOV) Stock Price, News & Analysis

Company Overview

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.

Key Stats

• Today's Range: $3.23 to $3.36
• 50-Day Range: $2.77 to $4.35
• 52-Week Range: $0.61 to $4.71
• Volume: 4.56 million shs
• Average Volume: 7.72 million shs
• Market Capitalization: $1.68 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $4.00
• Consensus Rating: Hold

Clover Health Investments Stock Analysis - MarketRank™

Clover Health Investments scored higher than 27% of companies evaluated by MarketBeat, and ranked 836th out of 963 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.0 / 5
• Analyst Rating: Hold

Consensus Rating

Clover Health Investments has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Clover Health Investments has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Clover Health Investments are expected to grow in the coming year, from ($0.12) to ($0.07) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Clover Health Investments is -16.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Clover Health Investments is -16.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Clover Health Investments has a P/B Ratio of 5.68. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.66% of the outstanding shares of Clover Health Investments have been sold short.

Short Interest Ratio / Days to Cover

Clover Health Investments has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Clover Health Investments has recently increased by 16.38%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Clover Health Investments does not currently pay a dividend.

Dividend Growth

Clover Health Investments does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

3.66% of the outstanding shares of Clover Health Investments have been sold short.

Short Interest Ratio / Days to Cover

Clover Health Investments has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Clover Health Investments has recently increased by 16.38%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.92

News Sentiment

Clover Health Investments has a news sentiment score of 0.92. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.45 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Clover Health Investments this week, compared to 3 articles on an average week.

Search Interest

Only 26 people have searched for CLOV on MarketBeat in the last 30 days. This is a decrease of -46% compared to the previous 30 days.

MarketBeat Follows

Only 9 people have added Clover Health Investments to their MarketBeat watchlist in the last 30 days. This is a decrease of -55% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Clover Health Investments insiders have not sold or bought any company stock.

Percentage Held by Insiders

22.28% of the stock of Clover Health Investments is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 19.77% of the stock of Clover Health Investments is held by institutions.

CLOV Stock Analysis - Frequently Asked Questions

How have CLOV shares performed this year?

Clover Health Investments' stock was trading at $0.9521 at the beginning of 2024. Since then, CLOV shares have increased by 251.9% and is now trading at $3.35.
View the best growth stocks for 2024 here.

How were Clover Health Investments' earnings last quarter?

Clover Health Investments, Corp. (NASDAQ:CLOV) announced its earnings results on Wednesday, November, 6th. The company reported ($0.02) EPS for the quarter, topping the consensus estimate of ($0.03) by $0.01. The firm had revenue of $330.99 million for the quarter, compared to analyst estimates of $347.60 million. Clover Health Investments had a negative trailing twelve-month return on equity of 25.46% and a negative net margin of 5.92%.

Who are Clover Health Investments' major shareholders?

Clover Health Investments' top institutional shareholders include Geode Capital Management LLC (0.97%), PNC Financial Services Group Inc. (0.97%), Charles Schwab Investment Management Inc. (0.60%) and State Street Corp (0.44%). Insiders that own company stock include Anna U Loengard, Chelsea Clinton and Chamath Palihapitiya.
View institutional ownership trends.

How do I buy shares of Clover Health Investments?

Shares of CLOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Clover Health Investments own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Clover Health Investments investors own include Zomedica (ZOM), AMC Entertainment (AMC), SoFi Technologies (SOFI), Jumia Technologies (JMIA), NIO (NIO), Meta Platforms (META) and NVIDIA (NVDA).

Company Calendar

• Last Earnings: 11/06/2024
• Today: 11/20/2024
• Fiscal Year End: 12/31/2024
• Next Earnings (Estimated): 3/11/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Hospital & medical service plans
• Sub-Industry: Insurance
• Current Symbol: NASDAQ:CLOV
• CUSIP: N/A
• CIK: 1801170
• Web: www.cloverhealth.com
• Phone: 201-432-2133
• Fax: N/A
• Employees: 552
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $4.00
• High Stock Price Target: $4.00
• Low Stock Price Target: $4.00
• Potential Upside/Downside: +19.4%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($0.20)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-213,360,000.00
• Net Margins: -5.92%
• Pretax Margin: -6.21%
• Return on Equity: -25.46%
• Return on Assets: -12.35%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.55
• Quick Ratio: 1.55

Sales & Book Value

• Annual Sales: $2.03 billion
• Price / Sales: 0.83
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.59 per share
• Price / Book: 5.68

Miscellaneous

• Outstanding Shares: 501,110,000
• Free Float: 389,462,000
• Market Cap: $1.68 billion
• Optionable: Optionable
• Beta: 2.03